Keywords: FV عامل V; APL, antiphospholipid antibody; DVT, deep venous thrombosis; E2, estradiol; FV, Factor V; HRT, hormone replacement therapy; ON, osteonecrosis; PE, pulmonary embolus; PTG, prothrombin gene mutation; T, testosterone; TT, testosterone therapy; VTE, venous th
مقالات ISI FV عامل V (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: FV عامل V; DVT, deep venous thrombosis; PE, pulmonary embolism; CTPA, computed tomographic pulmonary angiography; FV, Factor V; FVL, Factor V Leiden; PTM, prothrombin gene; MTHFR, Methylene Tetrahydrofolate Reductase; PAI-1, Plasminogen Activator Inhibitor-Type 1; V
The international normalized ratio according to Owren in liver disease: Interlaboratory assessment and determination of international sensitivity index
Keywords: FV عامل V; CV, coefficients of variation; EQUALIS, External Quality Assurance of Laboratory medicine; FII, factor II; FV, factor V; FVII, factor VII; FX, factor X; INR, international normalized ratio; ISI, international sensitivity index; ISIVKA, international sensi
Fatal pulmonary thromboembolism. A retrospective autopsy study: Searching for genetic thrombophilias (Factor V Leiden (G1691A) and FII (G20210A) gene variants) and dating the thrombus
Keywords: FV عامل V; DVT, Deep vein thrombosis; FII, factor II; FV, factor V; LMWH, low molecular weight heparin; PE, pulmonary embolism; PTE, pulmonary thromboembolism; UFH, unfractioned heparin; VTE, venous thromboembolismAcquired risk factors; Autopsy study; Factor V Leide
Mortality and recurrence after treatment of VTE: Long term follow-up of patients with good life-expectancy
Keywords: FV عامل V; AT, antithrombin; DVT, deep venous thrombosis; FV, factor V; HR, hazard ratio; INR, international normalised ratio; OA, oral anticoagulation; PE, pulmonary embolism; PC, protein C; PS, protein S; SMR, standardised mortality ratio; VTE, venous thromboembol
A Novel Mutation (G2172→C) in the Factor V Gene in a Chinese Family with Hereditary Activated Protein C Resistance
Keywords: FV عامل V; APC-R, Activated protein C resistance; VTE, venous thromboembolism; FV, factor V; APC, activated protein C; AT, antithrombin; PC, protein C; PS, protein S; aPTT, activated partial thromboplastin time; ACL, anticardiolipin antibodies; LA, lupus anticoagula
Shortened activated partial thromboplastin time, a hemostatic marker for hypercoagulable state during acute coronary event
Keywords: FV عامل V; ACS, acute coronary syndrome; APC-R, activated protein C resistance; APTT, activated partial thromboplastin time; CHD, coronary heart disease; CI, confidence interval; FV, factor V; FVIII, factor VIII; HUSM, Hospital Universisti Sains Malaysia; PPP, plate
Clinical evaluation of a new functional test for detection of activated protein C resistance (Pefakit® APC-R Factor V Leiden) at two centers in Europe and the USA
Keywords: FV عامل V; APC, activated protein C; aPTT, activated partial thromboplastin time; CT, clotting time; DTI, direct thrombin inhibitor; DUMC, Duke University Medical Center; FRET, fluorescence resonance energy transfer; FV, factor V; FVa, activated FV; FVL, factor V Le
The anticoagulant protein C pathway
Keywords: FV عامل V; APC, activated protein C; AT, antithrombin; CCP, complement control protein; C4BP, C4b-binding protein; EPCR, endothelial protein C receptor; EGF, epidermal growth factor; FV, factor V; Gla, γ-carboxy glutamic acid; LamG, laminin G-type; PCI, protein C in